LISATA THERAPEUTICS, INC. Deferred Income Tax Expense (Benefit)
LISATA THERAPEUTICS, INC. (LSTA) reported Deferred Income Tax Expense (Benefit) of -$962.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-12
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2012-06-30 was $325.90K, a 557.31% increase year-over-year.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2012-03-31 was -$325.90K.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2011-12-31 was $678.21K.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for the quarter ending 2011-09-30 was -$499.44K.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$962.00K.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$798.00K.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2023 was -$2.33M.
- LISATA THERAPEUTICS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$2.48M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 6 month as first filed | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | -$962.00K 10-K · filed 2026-03-12 | |||||
| 2024-12-31 | -$798.00K 10-K · filed 2026-03-12 | |||||
| 2023-12-31 | -$2.33M 10-K · filed 2025-02-27 | |||||
| 2022-12-31 | -$2.48M 10-K · filed 2024-02-29 | |||||
| 2021-12-31 | -$1.51M 10-K · filed 2023-03-30 | |||||
| 2020-12-31 | -$10.87M 10-K · filed 2022-03-22 | |||||
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | |||||
| 2018-12-31 | $0.00 10-K · filed 2019-03-14 | |||||
| 2017-12-31 | -$576.00K 10-K · filed 2019-03-14 | |||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-22 | $138.00K 10-K · filed 2017-03-17 | ||||
| 2015-12-31 | -$17.24M 10-K · filed 2017-03-17 | |||||
| 2014-12-31 | -$104.20K 10-K · filed 2016-03-15 | |||||
| 2013-12-31 | $780.10K 10-K · filed 2016-03-15 | $780.10K 10-K · filed 2014-03-13 | ||||
| 2012-12-31 | -$175.50K 10-K · filed 2015-03-02 | -$175.53K 10-K · filed 2013-03-11 | ||||
| 2012-06-30 | $325.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | $678.21K derived: sum of 3 quarters · filed 2013-03-11 | $178.77K derived: sum of 4 quarters · filed 2013-03-11 | ||
| 2012-03-31 | -$325.90K 10-Q · filed 2012-05-11 | $352.31K derived: sum of 2 quarters · filed 2013-03-11 | -$147.13K derived: sum of 3 quarters · filed 2013-03-11 | -$97.55K derived: sum of 4 quarters · filed 2013-03-11 | ||
| 2011-12-31 | $678.21K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | $178.77K derived: sum of 2 quarters · filed 2013-03-11 | $228.35K derived: sum of 3 quarters · filed 2013-03-11 | $0.00 10-K · filed 2013-03-11 | -$688.70K 10-K · filed 2012-03-20 | |
| 2011-09-30 | -$499.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$449.86K derived: sum of 2 quarters · filed 2012-08-14 | -$678.21K 10-Q · filed 2011-11-10 | -$1.33M derived: sum of 4 quarters · filed 2012-08-14 | ||
| 2011-06-30 | $49.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$178.77K 10-Q · filed 2012-08-14 | -$351.32K 10-Q · filed 2011-08-12 | -$827.03K derived: sum of 3 quarters · filed 2012-08-14 | -$888.21K derived: sum of 4 quarters · filed 2012-08-14 | |
| 2011-03-31 | -$228.35K 10-Q · filed 2012-05-11 | -$876.62K derived: sum of 2 quarters · filed 2012-05-11 | -$937.79K derived: sum of 3 quarters · filed 2012-05-11 | |||
| 2010-12-31 | -$648.26K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-20 | -$709.44K derived: sum of 2 quarters · filed 2012-03-20 | -$830.68K 10-K · filed 2012-03-20 | |||
| 2010-09-30 | -$61.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$182.42K 10-Q · filed 2011-11-10 | ||||
| 2010-06-30 | -$121.24K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |